A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Dobutamine
Deslanoside
The risk or severity of adverse effects can be increased when Dexamethasone is combined with Deslanoside.
Dobutamine
Digitoxin
The risk or severity of adverse effects can be increased when Dexamethasone is combined with Digitoxin.
Dobutamine
Isoniazid
The serum concentration of Isoniazid can be decreased when it is combined with Dexamethasone.
Dobutamine
Linagliptin
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Linagliptin.
Dobutamine
Balaglitazone
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Balaglitazone.
Dobutamine
Ciglitazone
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Ciglitazone.
Dobutamine
Rivoglitazone
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Rivoglitazone.
Dobutamine
Netoglitazone
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Netoglitazone.
Dobutamine
Lobeglitazone
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Lobeglitazone.
Dobutamine
Alogliptin
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Alogliptin.
Dobutamine
Saxagliptin
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Saxagliptin.
Dobutamine
Canagliflozin
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Canagliflozin.
Dobutamine
Dapagliflozin
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Dapagliflozin.
Dobutamine
Sitagliptin
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Sitagliptin.
Dobutamine
Ertugliflozin
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Ertugliflozin.
Dobutamine
Gastric inhibitory polypeptide
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Gastric inhibitory polypeptide.
Dobutamine
Tirzepatide
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Tirzepatide.
Dobutamine
Englitazone
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Englitazone.
Dobutamine
Taspoglutide
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Taspoglutide.
Dobutamine
Semaglutide
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Semaglutide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3